New combo drug trial aims to gauge safety in Parkinson's patients
NCT ID NCT07170475
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 29 times
Summary
This study tests the safety of taking febuxostat and inosine together twice daily for 12 weeks in 24 adults with early-stage Parkinson's disease. Participants must be on stable Parkinson's medications and will have regular blood tests and checkups. The main goal is to measure changes in a blood chemical called hypoxanthine. While there is no guarantee of direct benefit, the results will help design future treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE (PD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fujita Health University
RECRUITINGToyoake, Aichi-ken, 470-1192, Japan
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.